Pengaruh Puasa Ramadhan terhadap Kadar Neuropeptida Y pada Remaja Obesitas dan Overweight

Raden Ayu Tanzila

Abstract


Obesitas pada remaja merupakan masalah kesehatan yang semakin meningkat, dengan dampak serius terhadap metabolisme dan risiko penyakit kronis. Puasa Ramadan diketahui dapat mempengaruhi pola makan dan metabolisme energi, tetapi pengaruhnya terhadap kadar Neuropeptida Y (NPY) sebagai regulator nafsu makan masih belum banyak diteliti, terutama pada remaja obesitas dan overweight di Kota Palembang. Penelitian ini merupakan studi observasional kohort yang melibatkan 80 remaja laki-laki obesitas dan overweight yang melakukan puasa dan kelompok kontrol yang tidak puasa. Pengukuran kadar NPY dilakukan sebelum dan setelah puasa Ramadan menggunakan metode ELISA, sementara nafsu makan subjektif diukur dengan kuesioner Adult Eating Behaviour Questionnaire (AEBQ). Analisis data dilakukan menggunakan uji statistik univariat dan bivariat. Hasil penelitian menunjukkan bahwa puasa Ramadan secara signifikan meningkatkan food avoidance dan menurunkan food approach pada kelompok obesitas dan overweight (p<0,05). Namun, tidak ditemukan perubahan bermakna pada kadar NPY sebelum dan setelah puasa Ramadan (p>0,05). Simpulan yang didapat adalah puasa ramadan memiliki efek signifikan terhadap pola nafsu makan subjektif pada remaja obesitas dan overweight, tetapi tidak secara signifikan mempengaruhi kadar NPY. Temuan ini menunjukkan bahwa puasa Ramadan dapat menjadi intervensi awal yang baik dalam mengubah kebiasaan makan, meskipun mekanisme molekuler yang mendasari efek ini memerlukan penelitian lebih lanjut.


References


Riskesdas. Laporan Nasional Riskesdas 2018. Kementrian Kesehatan Republik Indonesia. 2018;

Dettoni R, Bahamondes C, Yevenes C, Cespedes C, Espinosa J. The effect of obesity on chronic diseases in USA: a flexible copula approach. Sci Rep. 2023;13(1).

Tootee A, Larijan B. Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update. Vol. 20, Journal of Diabetes and Metabolic Disorders. 2021.

Javanmard S, Otroj Z. Ramadan fasting and risk of Covid-19. Int J Prev Med. 2020;11(1).

Bandarian F, Namazi N, Atlasi R, Nasli-Esfahani E, Larijani B. Research gaps in Ramadan fasting studies in health and disease. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2021;15(3).

Ekawaty F, Makeama L, Yuliana Y, Sulistiawan A. Skrining obesitas dan edukasi dampak obesitas pada anak di SDN 49/IV Kota Jambi. Medical Dedication (medic) : Jurnal Pengabdian kepada Masyarakat FKIK UNJA. 2021;3(2).

( Harvie, M.dkk 2013 ). Pengaruh Puasa Intermiten 5:2 terhadap Berat Badan dan Resistensi Insulin pada Karyawan Obesitas di Jakarta. Amerta Nutrition. 2021;5(2).

Thackray AE, Willis SA, Clayton DJ, Broom DR, Finlayson G, Goltz FR, et al. Influence of short-term hyperenergetic, high-fat feeding on appetite, appetite-related hormones, and food reward in healthy men. Nutrients. 2020;12(9).

Stubbs RJ, Finlayson GS, Blundell JE. Appetite: Psychobiological and behavioral aspects. In: Encyclopedia of Human Nutrition: Volume 1-4, Fourth Edition. 2023.

Harrold JA, Halford JCG. Appetite: Physiological and Neurobiological Aspects. In: Encyclopedia of Human Nutrition. 2012.

Longo VD, Panda S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Vol. 23, Cell Metabolism. 2016.

Anton SD, Lee SA, Donahoo WT, McLaren C, Manini T, Leeuwenburgh C, et al. The effects of time restricted feeding on overweight, older adults: A pilot study. Nutrients. 2019;11(7).

Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: A review of human and animal trials. Vol. 86, American Journal of Clinical Nutrition. 2007.

Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. British Journal of Nutrition. 2013;110(8).

Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, et al. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity. 2016;24(9).

Tripolt NJ, Stekovic S, Aberer F, Url J, Pferschy PN, Schröder S, et al. Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial. Adv Ther. 2018;35(8).

Angoorani P, Ejtahed HS, Hasani-Ranjbar S, Siadat SD, Soroush AR, Larijani B. Gut microbiota modulation as a possible mediating mechanism for fasting-induced alleviation of metabolic complications: a systematic review. Vol. 18, Nutrition and Metabolism. 2021.

Gabel K, Marcell J, Cares K, Kalam F, Cienfuegos S, Ezpeleta M, et al. Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study. Nutr Health. 2020;26(2).

Zeb F, Wu X, Chen L, Fatima S, Haq IU, Chen A, et al. Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males. British Journal of Nutrition. 2020;123(11).

Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: Effects on body weight, body composition, and energy metabolism. American Journal of Clinical Nutrition. 2005;81(1).

Katus U, Villa I, Ringmets I, Veidebaum T, Harro J. Neuropeptide Y gene variants in obesity, dietary intake, blood pressure, lipid and glucose metabolism: A longitudinal birth cohort study. Peptides (NY). 2021;139.

Tang HN, Xiao F, Chen YR, Zhuang SQ, Guo Y, Wu HX, et al. Higher Serum Neuropeptide y Levels Are Associated with Metabolically Unhealthy Obesity in Obese Chinese Adults: A Cross-Sectional Study. Mediators Inflamm. 2020;2020.

Kassab SE, Abdul-Ghaffar T, Nagalla DS, Sachdeva U, Nayar U. Interactions between leptin, neuropeptide-Y and insulin with chronic diurnal fasting during Ramadan. Ann Saudi Med. 2004;24(5).

Correia MLG, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Hemodynamic consequences of neuropeptide Y-induced obesity. Am J Hypertens. 2002;15(2 I).

Huang Y, Lin X, Lin S. Neuropeptide Y and Metabolism Syndrome: An Update on Perspectives of Clinical Therapeutic Intervention Strategies. Vol. 9, Frontiers in Cell and Developmental Biology. 2021.

Sainsbury A, Wilks D, Cooney GJ. Interaction between adrenal glucocorticoids and parasympathetic activation in mediating hyperinsulinaemia during long-term central neuropeptide Y infusion in rats. Diabetologia. 2000;43(7).




DOI: https://doi.org/10.32502/sm.v15i2.9609

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Raden Ayu Tanzila

License URL: http://creativecommons.org/licenses/by-nd/4.0/

   

Statistic counter 

sinta4